A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Infection and Immunity

• Publication date

  1984-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.45.3.775-777.1984PMID 6540756PMCID PMC263365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes.

  1984cited by this paper
• Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.

  1983cited by this paper
• Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

  1983cited by this paper
• Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. I. Zygote surface antigens.

  1983cited by this paper
• Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations.

  1979cited by this paper
• Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor.

  1979cited by this paper
• Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro

  1978cited by this paper
• Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion

  1976cited by this paper
• Successful immunization against the sexual stages of Plasmodium gallinaceum.

  1976cited by this paper

• Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges

  2023cites this paper
• Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.

  2023cites this paper
• Efforts to Develop Pfs25 Vaccines.

  2022cites this paper
• Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China

  2022cites this paper
• On Malaria Transmission and Transmission Blocking Immunity.

  2022cites this paper
• Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?

  2021cites this paper
• A malaria parasite phospholipid flippase safeguards midgut traversal of ookinetes for mosquito transmission

  2021cites this paper
• Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice

  2021cites this paper
• An intracellular membrane protein GEP1 regulates xanthurenic acid induced gametogenesis of malaria parasites

  2020cites this paper
• Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice

  2020cites this paper
• Malaria vaccines since 2000: progress, priorities, products

  2020cites this paper
• Purification and production of Plasmodium falciparum zygotes from in vitro culture using magnetic column and Percoll density gradient

  2020cites this paper
• Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development

  2019cites this paper
• Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolates.

  2019cites this paper
• Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

  2018cites this paper
• Antimalarial Transmission-Blocking Interventions: Past, Present, and Future.

  2018cites this paper
• Translational repression of the cpw-wpc gene family in the malaria parasite Plasmodium.

  2016cites this paper
• Development of malaria transmission-blocking vaccines: from concept to product.

  2015cites this paper
• Recombinant Pvs48/45 Antigen Expressed in E. coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes

  2015cites this paper
• In vivo transmission blocking activities of artesunate on the avian malaria parasite Plasmodium gallinaceum.

  2013cites this paper
• Effets des antipaludiques sur les stades hépatiques et les stades sexués (transmission) des plasmodies murines, Plasmodium yoelii

  2011cites this paper
• Plasmodium vivax: who cares?

  2008cites this paper
• Malaria stage-specific vaccine candidates.

  2007cites this paper
• Mosquito stage, transmission blocking vaccines for malaria

  2007cites this paper
• Do malaria ookinete surface proteins P25 and P28 mediate parasite entry into mosquito midgut epithelial cells?

  2005cites this paper
• Babesia bigemina sexual stages are induced in vitro and are specifically recognized by antibodies in the midgut of infected Boophilus microplus ticks.

  2004cites this paper
• Pfs230: from malaria transmission‐blocking vaccine candidate toward function

  2003cites this paper
• Transmission-blocking vaccine of vivax malaria.

  2003cites this paper
• Inhibition of Ca2+/Calmodulin-dependent Protein Kinase Blocks Morphological Differentiation of Plasmodium gallinaceum Zygotes to Ookinetes*

  2002cites this paper
• Plasmodium berghei: routine production of pure gametocytes, extracellular gametes, zygotes, and ookinetes.

  2002cites this paper
• Transmission blocking malaria vaccines.

  2001cites this paper
• Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism.

  2001cites this paper
• 3' UTR elements enhance expression of Pgs28, an ookinete protein of Plasmodium gallinaceum.

  2000cites this paper
• Characterisation and expression of pbs25, a sexual and sporogonic stage specific protein of Plasmodium berghei.

  2000cites this paper
• Plasmodium ookinete development in the mosquito midgut: a case of reciprocal manipulation

  1998cites this paper
• Mechanisms of naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria

  1998cites this paper
• Mapping of Specific and Promiscuous HLA-DR-Restricted T-Cell Epitopes on the Plasmodium falciparum 27-Kilodalton Sexual Stage-Specific Antigen

  1998cites this paper
• Antimalarial transmission-blocking vaccines.

  1997cites this paper
• Transmission-blocking vaccines: uses and current status of development.

  1997cites this paper
• Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity

  1997influential citation
• Primary structure of a novel ookinete surface protein from Plasmodium berghei.

  1997cites this paper
• The biology of malarial parasite in the mosquito--a review.

  1996cites this paper
• Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies.

  1995cites this paper
• Plasmodium gallinaceum: a refractory mechanism of ookinete killing in the mosquito, Anopheles gambiae.

  1995cites this paper
• Expression of the Plasmodium berghei ookinete protein Pbs21 in a baculovirus‐insect cell system produces an efficient transmission blocking immunogen

  1995cites this paper
• Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum

  1994influential citation
• Kinetics of Expression of Two Major Plasmodium berghei Antigens in the Mosquito Vector, Anopheles stephensi

  1993cites this paper
• Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies

  1993cites this paper
• Transfection of the malaria parasite and expression of firefly luciferase.

  1993cites this paper
• Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product

  1993cites this paper
• Transmission-blocking immunity against malaria and other vector-borne diseases.

  1993cites this paper
• Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum.

  1992cites this paper
• Immunoaffinity chromatography using electroelution.

  1992cites this paper
• Defence mechanisms and immune evasion in the interplay between the humane immune system and Plasmodium falciparum.

  1992cites this paper
• Further characterization of interactions between gamete surface antigens of Plasmodium falciparum.

  1992cites this paper
• Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei

  1991cites this paper
• Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

  1991cites this paper
• The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes.

  1991cites this paper
• Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum

  1990cites this paper
• Vaccinations in Health Strategies of Developing Countries: The Role of Biotechnology and Social Sciences

  1990cites this paper
• Immunity to sexual stages of human malaria parasites: immune modulation during natural infections, antigenic determinants, and the induction of transmission-blocking immunity.

  1990cites this paper
• Primary structure of the 25-kilodalton ookinete antigen from Plasmodium reichenowi.

  1990cites this paper
• Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions.

  1989cites this paper
• Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.

  1989cites this paper
• Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies

  1989cites this paper
• Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kD determinant identified by transmission‐blocking monoclonal antibodies

  1988cites this paper
• Immunity to sexual stages of malaria parasites.

  1988cites this paper
• Plasmodium falciparum: natural and experimental transmission-blocking immunity.

  1988cites this paper
• The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.

  1987cites this paper
• Complement effects of the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. II. Changes in sensitivity to complement-like factors during zygote development.

  1987cites this paper
• Ookinete antigens of Plasmodium berghei: a light and electron-microscope immunogold study of expression of the 21 kDa determinant recognized by a transmission-blocking antibody

  1987cites this paper
• Research toward malaria vaccines.

  1986cites this paper
• Phase separation in Triton X-114 of antigens of transmission blocking immunity in Plasmodium gallinaceum.

  1985cites this paper
• Comparative biology of intracellular parasitism.

  1985cites this paper
• Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes.

  1985cites this paper
• Comparative biology of intracellular parasitism

  1985cites this paper
• Plasmodium gallinaceum: critical role for microtubules in the transformation of zygotes into Ookinetes.

  1985cites this paper